I am very optimistic also. I feel a few years from now, we
I am very optimistic also. I feel a few years from now, we are going to be using leronlimab commercially with lots of ccr5+ cancers. 15B+ sales and climbing... but just my opinion.
Yes, I also noticed NP saying that. Maybe misiu will respond with an opinion, she knows more about the tnbc trial then anyone outside of cydy's people imo.
But in the original PR, they mention an initial readout and also filing BTD if original results are good.
"CytoDyn has identified five clinical trial sites and intends to dose its first several patients and expects to have initial readout during the first quarter of 2019. The change in circulating tumor cells (CTCs) number will be evaluated every 21 days during treatment and will be used as an initial prognostic marker for efficacy."
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SEC Adjusts Enforcement Focus to Address Cyber Fraud The U.S. Securities and Exchange Commission (SEC) is making significant changes to its enforcement strategy, signaling a shift from its previous stance on cryptocurrency regulation. This restructuring involves scaling back its cryptocurrency oversight unit and creating a specialized team dedicated to tackling cyber...
Continue Reading
Notable Shifts in DuPont Stock Sentiment The whispers in the market are getting harder to ignore—DuPont de Nemours Inc (NYSE:DD) is seeing some serious strife under its surface. Just recently, the short interest on this stock has crept up by a hefty 23.76%. Folks, that’s not just a passing trend; it’s a flashing neon sign that says something's off in the minds of...
Continue Reading
Unlocking Your Potential: The Power of Muscle Building In an age where fitness lies at the forefront of many people's aspirations, finding a solid workout routine tailored for muscle growth has never been more critical. For men looking for rapid muscle development, CrazyBulk muscle gaining supplements are setting a new standard in the fitness community. This approach...
Continue Reading
Goldswarm Honey Takes a Sweet Step for Pollinators A new partnership has blossomed between Goldswarm Honey and a renowned research institution aimed at safeguarding the vital pollinators that are essential to a significant portion of our food supply. This collaboration not only highlights a deep commitment to environmental conservation but also bridges two cultures...
Continue Reading
Idexx Laboratories Faces Revenue Growth Challenges Idexx Laboratories Inc (NASDAQ: IDXX) reported its third-quarter earnings, showcasing an adjusted EPS of $2.79. This reflected a remarkable 12% increase compared to the previous year, surpassing analyst expectations which were set at $2.68. Sales Performance Overview During this quarter, the company achieved sales...
Continue Reading
